Literature DB >> 22171142

Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?

Andrea Ruzzenente1, Alessandro Valdegamberi, Tommaso Campagnaro, Simone Conci, Silvia Pachera, Calogero Iacono, Alfredo Guglielmi.   

Abstract

AIM: To analyze the outcome of hepatocellular carcinoma (HCC) resection in cirrhosis patients, related to presence of portal hypertension (PH) and extent of hepatectomy.
METHODS: A retrospective analysis of 135 patients with HCC on a background of cirrhosis was submitted to curative liver resection.
RESULTS: PH was present in 44 (32.5%) patients. Overall mortality and morbidity were 2.2% and 33.7%, respectively. Median survival time in patients with or without PH was 31.6 and 65.1 mo, respectively (P = 0.047); in the subgroup with Child-Pugh class A cirrhosis, median survival was 65.1 mo and 60.5 mo, respectively (P = 0.257). Survival for patients submitted to limited liver resection was not significantly different in presence or absence of PH. Conversely, median survival for patients after resection of 2 or more segments with or without PH was 64.4 mo and 163.9 mo, respectively (P = 0.035).
CONCLUSION: PH is not an absolute contraindication to liver resection in Child-Pugh class A cirrhotic patients, but resection of 2 or more segments should not be recommended in patients with PH.

Entities:  

Keywords:  Hepatic resection; Hepatocellular carcinoma; Liver surgery; Portal hypertension

Mesh:

Year:  2011        PMID: 22171142      PMCID: PMC3235591          DOI: 10.3748/wjg.v17.i46.5083

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  C-C Wu; S-B Cheng; W-M Ho; J-T Chen; T-J Liu; F-K P'eng
Journal:  Br J Surg       Date:  2005-03       Impact factor: 6.939

Review 2.  Portal hypertension and its complications.

Authors:  Arun J Sanyal; Jaime Bosch; Andres Blei; Vincente Arroyo
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 3.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Influence of the extent of hepatectomy on the portal hypertensive state in patients with hepatoma.

Authors:  S Fujisaki; H Miyake; S Amano; H Nakayama; R Tomita; M Fukuzawa
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

5.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

Review 6.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

7.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

8.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

9.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

10.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

View more
  19 in total

1.  Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy.

Authors:  Andrea Belli; Luigi Cioffi; Gianluca Russo; Giulio Belli
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

Review 2.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

Authors:  Ali Raza; Gagan K Sood
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  New paradigms in post-hepatectomy liver failure.

Authors:  Nicolas Golse; Petru O Bucur; René Adam; Denis Castaing; Antonio Sa Cunha; Eric Vibert
Journal:  J Gastrointest Surg       Date:  2012-11-18       Impact factor: 3.452

4.  Liver resections between 2014 and 2020 in the Lausanne University Hospital, Switzerland.

Authors:  Kosuke Kobayashi; Emilie Uldry; Nicolas Demartines; Nermin Halkic
Journal:  Glob Health Med       Date:  2020-10-31

Review 5.  Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Authors:  Gonzalo Sapisochin; Elena Fernandez de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2014-11-27

6.  Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.

Authors:  Astrit R Hamza; Avdyl S Krasniqi; Pramod Kadaba Srinivasan; Mamdouh Afify; Christian Bleilevens; Uwe Klinge; René H Tolba
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 7.  Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

Authors:  Mark Pines
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

8.  Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?

Authors:  Roberto Santambrogio; Michael D Kluger; Mara Costa; Andrea Belli; Matteo Barabino; Alexis Laurent; Enrico Opocher; Daniel Azoulay; Daniel Cherqui
Journal:  HPB (Oxford)       Date:  2012-10-24       Impact factor: 3.647

9.  Safety validation of decision trees for hepatocellular carcinoma.

Authors:  Xian-Qiang Wang; Zhe Liu; Wen-Ping Lv; Ying Luo; Guang-Yun Yang; Chong-Hui Li; Xiang-Fei Meng; Yang Liu; Ke-Sen Xu; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 10.  Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Simone Conci; Alessandro Valdegamberi; Marco Vitali; Francesca Bertuzzo; Michela De Angelis; Guido Mantovani; Calogero Iacono
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.